No significant differences in adverse events were observed.<h4>Conclusions</h4>SEM combined with insulin therapy effectively controls BG, improves insulin function, and may offer short-term renal protective benefits in elderly diabetes patients; however, long-term studies are needed to confirm effects on CKD progression. Here, INS is linked to diabetes mellitus.